These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 10998462)
1. Effects of probucol on cholesterol metabolism in mouse peritoneal macrophages: inhibition of HDL-mediated cholesterol efflux. Takemura T; Sakai M; Matsuda H; Matsumura T; Biwa T; Anami Y; Nishikawa T; Sasahara T; Shichiri M Atherosclerosis; 2000 Oct; 152(2):347-57. PubMed ID: 10998462 [TBL] [Abstract][Full Text] [Related]
2. High-density lipoproteins from probucol-treated patients have increased capacity to promote cholesterol efflux from mouse peritoneal macrophages loaded with acetylated low-density lipoproteins. Ishigami M; Yamashita S; Sakai N; Hirano K; Arai T; Maruyama T; Takami S; Koyama M; Kameda-Takemura K; Matsuzawa Y Eur J Clin Invest; 1997 Apr; 27(4):285-92. PubMed ID: 9134376 [TBL] [Abstract][Full Text] [Related]
3. Selective inhibition of free apolipoprotein-mediated cellular lipid efflux by probucol. Tsujita M; Yokoyama S Biochemistry; 1996 Oct; 35(40):13011-20. PubMed ID: 8855936 [TBL] [Abstract][Full Text] [Related]
4. Apolipoprotein-mediated cellular cholesterol/phospholipid efflux and plasma high density lipoprotein level in mice. Tsujita M; Tomimoto S; Okumura-Noji K; Okazaki M; Yokoyama S Biochim Biophys Acta; 2000 May; 1485(2-3):199-213. PubMed ID: 10832100 [TBL] [Abstract][Full Text] [Related]
5. Pharmacologic suppression of hepatic ATP-binding cassette transporter 1 activity in mice reduces high-density lipoprotein cholesterol levels but promotes reverse cholesterol transport. Yamamoto S; Tanigawa H; Li X; Komaru Y; Billheimer JT; Rader DJ Circulation; 2011 Sep; 124(12):1382-90. PubMed ID: 21859969 [TBL] [Abstract][Full Text] [Related]
6. Probucol-Oxidized Products, Spiroquinone and Diphenoquinone, Promote Reverse Cholesterol Transport in Mice. Yakushiji E; Ayaori M; Nishida T; Shiotani K; Takiguchi S; Nakaya K; Uto-Kondo H; Ogura M; Sasaki M; Yogo M; Komatsu T; Lu R; Yokoyama S; Ikewaki K Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):591-7. PubMed ID: 26848156 [TBL] [Abstract][Full Text] [Related]
7. Effects of NTE-122, a novel acyl-CoA:cholesterol acyltransferase inhibitor, on cholesterol esterification and high-density lipoprotein-induced cholesterol efflux in macrophages. Azuma Y; Kawasaki T; Ikemoto K; Ohno K; Yamada T; Yamasaki M; Nobuhara Y Jpn J Pharmacol; 1999 Feb; 79(2):159-67. PubMed ID: 10202851 [TBL] [Abstract][Full Text] [Related]
8. Protein synthesis inhibition in mouse peritoneal macrophages results in increased acyl coenzyme A:cholesterol acyl transferase activity and cholesteryl ester accumulation in the presence of native low density lipoprotein. Tabas I; Boykow GC J Biol Chem; 1987 Sep; 262(25):12175-81. PubMed ID: 3624250 [TBL] [Abstract][Full Text] [Related]
9. Impaired mobilisation of cholesterol from stored cholesteryl esters in human (THP-1) macrophages. Graham A; Angell AD; Jepson CA; Yeaman SJ; Hassall DG Atherosclerosis; 1996 Feb; 120(1-2):135-45. PubMed ID: 8645354 [TBL] [Abstract][Full Text] [Related]
10. Effects of probucol on atherosclerosis of apoE-deficient or LDL receptor-deficient mice. Yoshikawa T; Shimano H; Chen Z; Ishibashi S; Yamada N Horm Metab Res; 2001 Aug; 33(8):472-9. PubMed ID: 11544561 [TBL] [Abstract][Full Text] [Related]
11. Influence of native and modified lipoproteins on migration of mouse peritoneal macrophages and the effect of the antioxidants vitamin E and Probucol. Trach CC; Wülfroth PM; Severs NJ; Robenek H Eur J Cell Biol; 1996 Oct; 71(2):199-205. PubMed ID: 8905298 [TBL] [Abstract][Full Text] [Related]
12. Effect of the ACAT inhibitor, HL-004, on cholesterol metabolism in macrophages. Murakami S; Yamagishi I; Asami Y; Sato M; Tomisawa K Cell Mol Biol (Noisy-le-grand); 1996 Sep; 42(6):865-72. PubMed ID: 8891354 [TBL] [Abstract][Full Text] [Related]
13. An inhibitor of acylCoA: cholesterol acyltransferase increases expression of ATP-binding cassette transporter A1 and thereby enhances the ApoA-I-mediated release of cholesterol from macrophages. Sugimoto K; Tsujita M; Wu CA; Suzuki K; Yokoyama S Biochim Biophys Acta; 2004 Feb; 1636(1):69-76. PubMed ID: 14984740 [TBL] [Abstract][Full Text] [Related]
14. Probucol alleviates atherosclerosis and improves high density lipoprotein function. Zhong JK; Guo ZG; Li C; Wang ZK; Lai WY; Tu Y Lipids Health Dis; 2011 Nov; 10():210. PubMed ID: 22078494 [TBL] [Abstract][Full Text] [Related]
15. Effect of probucol in lecithin-cholesterol acyltransferase-deficient mice: inhibition of 2 independent cellular cholesterol-releasing pathways in vivo. Tomimoto S; Tsujita M; Okazaki M; Usui S; Tada T; Fukutomi T; Ito S; Itoh M; Yokoyama S Arterioscler Thromb Vasc Biol; 2001 Mar; 21(3):394-400. PubMed ID: 11231919 [TBL] [Abstract][Full Text] [Related]
16. Cytotoxic cellular cholesterol is selectively removed by apoA-I via ABCA1. Kellner-Weibel G; Luke SJ; Rothblat GH Atherosclerosis; 2003 Dec; 171(2):235-43. PubMed ID: 14644392 [TBL] [Abstract][Full Text] [Related]
17. Effects of high-density lipoprotein(2) on cholesterol transport and acyl-coenzyme A:cholesterol acyltransferase activity in P388D1 macrophages. Li L; Pownall HJ Biochim Biophys Acta; 2001 Jan; 1530(1):111-22. PubMed ID: 11341963 [TBL] [Abstract][Full Text] [Related]
18. HDL is essential for atherosclerotic lesion regression in Apoe knockout mice by bone marrow Apoe reconstitution. van der Sluis RJ; Verwilligen RAF; Lendvai Z; Wever R; Hoekstra M; Van Eck M Atherosclerosis; 2018 Nov; 278():240-249. PubMed ID: 30340108 [TBL] [Abstract][Full Text] [Related]
19. Anti-atherogenic effects of the acyl-CoA:cholesterol acyltransferase inhibitor, avasimibe (CI-1011), in cultured primary human macrophages. Rodriguez A; Usher DC Atherosclerosis; 2002 Mar; 161(1):45-54. PubMed ID: 11882316 [TBL] [Abstract][Full Text] [Related]
20. Lipoproteins activate acyl-coenzyme A:cholesterol acyltransferase in macrophages only after cellular cholesterol pools are expanded to a critical threshold level. Xu XX; Tabas I J Biol Chem; 1991 Sep; 266(26):17040-8. PubMed ID: 1894601 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]